Literature DB >> 22289786

From the field of play to the field of combat: a review of the pharmacological management of concussion.

Anthony L Petraglia1, Joseph C Maroon, Julian E Bailes.   

Abstract

Traditionally, the medical management of concussion has involved close observation and physical and cognitive rest. Most postconcussive symptoms resolve spontaneously and require only conservative treatment. However, some patients have prolonged recoveries and may benefit from treatment with medications. Some naturally occurring compounds demonstrate multimechanistic neuroprotective properties and may be potential treatment considerations. For the most part, however, current treatments are symptom based for those with persistent postconcussive symptoms. The evidence supporting the various pharmacologic treatments in concussion is equivocal. The choice of which medication to use for a patient depends on the symptom characteristics, and each decision should be made on an individual-case basis. There is a need for well-designed trials investigating the efficacy of various medical therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289786     DOI: 10.1227/NEU.0b013e31824cebe8

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  19 in total

1.  The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic encephalopathy.

Authors:  Anthony L Petraglia; Benjamin A Plog; Samantha Dayawansa; Michael Chen; Matthew L Dashnaw; Katarzyna Czerniecka; Corey T Walker; Tyler Viterise; Ollivier Hyrien; Jeffrey J Iliff; Rashid Deane; Maiken Nedergaard; Jason H Huang
Journal:  J Neurotrauma       Date:  2014-06-12       Impact factor: 5.269

Review 2.  Prognostic Factors in Pediatric Sport-Related Concussion.

Authors:  Scott L Zuckerman; Benjamin L Brett; Aaron S Jeckell; Aaron M Yengo-Kahn; Gary S Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-05       Impact factor: 5.081

Review 3.  Current and emerging rehabilitation for concussion: a review of the evidence.

Authors:  Steven P Broglio; Michael W Collins; Richelle M Williams; Anne Mucha; Anthony P Kontos
Journal:  Clin Sports Med       Date:  2015-01-24       Impact factor: 2.182

4.  Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury.

Authors:  Brittany V Daiutolo; Ashley Tyburski; Shannon W Clark; Melanie B Elliott
Journal:  J Neurotrauma       Date:  2015-12-17       Impact factor: 5.269

5.  An empirical review of treatment and rehabilitation approaches used in the acute, sub-acute, and chronic phases of recovery following sports-related concussion.

Authors:  R J Elbin; Phil Schatz; Harrison B Lowder; Anthony P Kontos
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 6.  Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-06       Impact factor: 21.566

7.  The influence of chronic cigarette smoking on neurocognitive recovery after mild traumatic brain injury.

Authors:  Timothy C Durazzo; Linda Abadjian; Adam Kincaid; Tobias Bilovsky-Muniz; Lauren Boreta; Grant E Gauger
Journal:  J Neurotrauma       Date:  2013-06-06       Impact factor: 5.269

Review 8.  The clinical spectrum of sport-related traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Nat Rev Neurol       Date:  2013-03-12       Impact factor: 42.937

9.  A Case for Mental and Physical Rest in Youth Sports Concussion: It's Never too Late.

Authors:  Rosemarie Scolaro Moser; Philip Schatz
Journal:  Front Neurol       Date:  2012-12-11       Impact factor: 4.003

Review 10.  ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion.

Authors:  Erin Cernkovich Barrett; Michael I McBurney; Eric D Ciappio
Journal:  Adv Nutr       Date:  2014-05-14       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.